Cladribine Tablets Receives Positive CHMP Opinion for Treatment of Relapsing Forms of Multiple Sclerosis June 23, 2017October 19, 2019 by / Share This.....LinkedinTwitterFacebookGoogleEmailDownload PDF Related News: Data up to 8-years for Roche’s OCREVUS (ocrelizumab)…New data for Roche’s OCREVUS (ocrelizumab) show…Roche to present new OCREVUS (ocrelizumab) data in…CHMP recommends EU approval of Roche’s Tecentriq as…Roche announces positive Phase III results for…European Commission approves Roche’s Gavreto…
